According to the latest statistics from the CDC, more than 50 million Americans suffer from chronic, debilitating pain. Pain presents in a variety of ways, including acute and chronic, pain from accidents, diseases, neuropathy, osteoarthritis, degenerative joint disease and syndromes like fibromyalgia.
For decades, patients have been presented only with conventional treatment methods to relieve their pain including surgery, injections, and medications such as opioids. This approach led us down the path of addiction, resulting in a rapidly growing epidemic of overdose deaths, ineffective procedures and surgeries that placed a heavy burden on the healthcare system and in some cases, failed to provide the relief patients needed.
Neuragenex uses innovative, non-invasive, non-opioid, research-based solutions. These include but are not limited to Combined Electrochemical Treatment (CET), Remote Therapeutic Monitoring (RTM), and our patented Neurassage therapeutic technique, helping to target, manage, reduce, and eliminate acute and chronic pain.